Abstract

Activation of AMP-activated kinase (AMPK) in skeletal muscle increases FA oxidation by inducing Acetyl-CoA Carboxylaze (ACC) deactivation. However, the upstream signal molecules that activate AMPK/ACC signaling remains unclear. It is expected that Fatty Acid Translocase (FAT/CD36) will become another potential target for diabetic therapy after AMPK. PURPOSE: To explore the role of CD36, as a signal molecule, in regulating the upstream signaling pathway of AMPK/ACC in skeletal muscle under HFD conditions. METHODS: First, siRNA interference was used to knock down CD36 gene in C2C12 cells to investigate the effect of CD36 deficiency on the phosphorylation of AMPK/ACC signaling in skeletal muscle cells. Then, twelve 8-week-old C57BL/6 male mice were randomly divided into two groups: control group (CON; n = 6), and high-fat diet group (HFD; n = 6). The expression levels of CD36 protein and phosphorylation of AMPK/ACC signaling under HFD conditions were detected by Western blotting method; the translocation of Liver kinase B1 (LKB1) in nucleus was detected by immunofluorescence method; the ultrastructural changes of skeletal muscle were detected by transmission electron microscopy; and the activity of mitochondrial respiratory chain enzyme was detected by colorimetry. RESULTS: CD36 deficiency activated AMPK (0.129 ± 0.009 vs. 0.417 ± 0.055, p < 0.05), ACC (0.044 ± 0.008 vs. 0.081 ± 0.010, p < 0.05) signaling in skeletal muscle cells. Compared with the CON group, the expression levels of CD36 protein in HFD group were significantly increased (0.225± 0.041 vs. 0.506 ± 0.022, p < 0.01), the phosphorylation levels of AMPK (0.142 ± 0.020 vs. 0.079 ± 0.010, p < 0.05) and ACC (0.229 ± 0.023 vs. 0.119 ± 0.028, p < 0.05) were significantly decreased, and induced LKB1 translocation from cytoplasm to nucleus. In addition, electron microscopic results showed that HFD intervention damaged the mitochondrial structure of skeletal muscle to a certain extent, and significantly decreased CS activity (411.32 ± 22.15 vs. 310.20 ± 44.09, p < 0.01). CONCLUSION: CD36, as a signaling molecule, promotes LKB1 to translocate from cytoplasm to nucleus, which inhibits AMPK/ACC signaling activation, thereby regulating FA oxidation under HFD condition. Supported by the National Natural Science Foundation of China (No. 31600966).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call